Phospholipase D meets Wnt signaling: A new target for cancer therapy

Dong Woo Kang, Kang Yell Choi, Do Sik Min

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

Phospholipase D (PLD) has been increasingly recognized as a critical regulator of cell proliferation and tumorigenesis. PLD regulates downstream effectors by generating phosphatidic acid (PA), and the expression and activity of PLD are elevated in many different types of human cancer. Aberrant activation of Wnt/b-catenin signaling, followed by hyper-activation of target genes, is linked to a wide range of cancers. New studies reveal a direct connection between the PLD and the Wnt signaling pathways; PLD is a transcriptional target of β-catenin/ T-cell factor (TCF) and reinforces Wnt/β-catenin signaling related with cellular transformation. In this review, we discuss the emerging importance of PLD and PA in the Wnt/β-catenin signaling network, which is associated with tumorigenesis, and suggest that the PLD/PA signaling pathway is a potential therapeutic target for the treatment of cancer.

Original languageEnglish
Pages (from-to)293-297
Number of pages5
JournalCancer Research
Volume71
Issue number2
DOIs
Publication statusPublished - 2011 Jan 15

Fingerprint

Phospholipase D
Catenins
Phosphatidic Acids
Neoplasms
Therapeutics
Carcinogenesis
TCF Transcription Factors
Wnt Signaling Pathway
Transcriptional Activation
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{ed88bf95e5a04b50866edd9df76a6fcc,
title = "Phospholipase D meets Wnt signaling: A new target for cancer therapy",
abstract = "Phospholipase D (PLD) has been increasingly recognized as a critical regulator of cell proliferation and tumorigenesis. PLD regulates downstream effectors by generating phosphatidic acid (PA), and the expression and activity of PLD are elevated in many different types of human cancer. Aberrant activation of Wnt/b-catenin signaling, followed by hyper-activation of target genes, is linked to a wide range of cancers. New studies reveal a direct connection between the PLD and the Wnt signaling pathways; PLD is a transcriptional target of β-catenin/ T-cell factor (TCF) and reinforces Wnt/β-catenin signaling related with cellular transformation. In this review, we discuss the emerging importance of PLD and PA in the Wnt/β-catenin signaling network, which is associated with tumorigenesis, and suggest that the PLD/PA signaling pathway is a potential therapeutic target for the treatment of cancer.",
author = "Kang, {Dong Woo} and Choi, {Kang Yell} and Min, {Do Sik}",
year = "2011",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-10-2463",
language = "English",
volume = "71",
pages = "293--297",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

Phospholipase D meets Wnt signaling : A new target for cancer therapy. / Kang, Dong Woo; Choi, Kang Yell; Min, Do Sik.

In: Cancer Research, Vol. 71, No. 2, 15.01.2011, p. 293-297.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Phospholipase D meets Wnt signaling

T2 - A new target for cancer therapy

AU - Kang, Dong Woo

AU - Choi, Kang Yell

AU - Min, Do Sik

PY - 2011/1/15

Y1 - 2011/1/15

N2 - Phospholipase D (PLD) has been increasingly recognized as a critical regulator of cell proliferation and tumorigenesis. PLD regulates downstream effectors by generating phosphatidic acid (PA), and the expression and activity of PLD are elevated in many different types of human cancer. Aberrant activation of Wnt/b-catenin signaling, followed by hyper-activation of target genes, is linked to a wide range of cancers. New studies reveal a direct connection between the PLD and the Wnt signaling pathways; PLD is a transcriptional target of β-catenin/ T-cell factor (TCF) and reinforces Wnt/β-catenin signaling related with cellular transformation. In this review, we discuss the emerging importance of PLD and PA in the Wnt/β-catenin signaling network, which is associated with tumorigenesis, and suggest that the PLD/PA signaling pathway is a potential therapeutic target for the treatment of cancer.

AB - Phospholipase D (PLD) has been increasingly recognized as a critical regulator of cell proliferation and tumorigenesis. PLD regulates downstream effectors by generating phosphatidic acid (PA), and the expression and activity of PLD are elevated in many different types of human cancer. Aberrant activation of Wnt/b-catenin signaling, followed by hyper-activation of target genes, is linked to a wide range of cancers. New studies reveal a direct connection between the PLD and the Wnt signaling pathways; PLD is a transcriptional target of β-catenin/ T-cell factor (TCF) and reinforces Wnt/β-catenin signaling related with cellular transformation. In this review, we discuss the emerging importance of PLD and PA in the Wnt/β-catenin signaling network, which is associated with tumorigenesis, and suggest that the PLD/PA signaling pathway is a potential therapeutic target for the treatment of cancer.

UR - http://www.scopus.com/inward/record.url?scp=78751480479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751480479&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-2463

DO - 10.1158/0008-5472.CAN-10-2463

M3 - Review article

C2 - 21224347

AN - SCOPUS:78751480479

VL - 71

SP - 293

EP - 297

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -